Phenotypic and functional changes in glial cells as a function of age

Neurobiology of Aging

Volumn 23, Issue 1, 2002, Pages 105-115

  Yu, Wai H ^a,b   Go, Lynle ^a   Guinn, Barbara A ^d   Fraser, Paul E ^a,c   Westaway, David ^a,b   McLaurin, JoAnne ^a  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF TORONTO   (Canada)

^d KING'S COLLEGE LONDON   (United Kingdom)

Author keywords

Aging; Amyloid peptide; Astrocytes; Cytokines; Microglia; Neurotoxicity; Nitric oxide

Indexed keywords

AMYLOID BETA PROTEIN; CYTOKINE; INTERLEUKIN 1BETA; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA;

AGED; AGING; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASSAY; ASTROCYTE; CELL ACTIVATION; CELL STRUCTURE; CONTROLLED STUDY; IMMUNE SYSTEM; IN VITRO STUDY; IN VIVO STUDY; MICROGLIA; NERVE DEGENERATION; NEUROTOXICITY; NONHUMAN; PHENOTYPE; POSTNATAL DEVELOPMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT;

AGING; AMYLOID BETA-PROTEIN; ANIMALS; AUTORADIOGRAPHY; CELL DIVISION; CELL SEPARATION; CELLS, CULTURED; CEREBRAL CORTEX; COLORING AGENTS; CYTOKINES; FEMALE; L-LACTATE DEHYDROGENASE; NEUROGLIA; NEURONS; NITRIC OXIDE; NUCLEASE PROTECTION ASSAYS; PC12 CELLS; PHENOTYPE; RATS; RATS, INBRED F344; RESPIRATORY BURST; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0036145444     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(01)00258-5     Document Type: Article

References (64)

1. Amyloid-β peptide stimulates nitric oxide production in astrocytes through an NF kB-dependent mechanism
2. Reduction and excitation of oxygen by phagocytic leukocytes: Biochemical and cytochemical techniques
3. Amyloid beta-protein toxicity and oxidative stress in Alzheimer's disease
4. Tumor necrosis factor α augments amyloid beta protein (25-35) induced apoptosis in human cells
5. Age-related toxicity to lactate, glutamate, and β-amyloid in cultured adult neurons
6. Release of excess amyloid beta protein from a mutant amyloid beta protein precursor
7. Transgenic mice and cytokine actions in the brain: Bridging the gap between structural and functional neuropathology
8. Cytokine production pathway in the elderly
9. Excessive production of amyloid beta-protein by peripheral cells of symptomatic and presymptomatic patients carrying the Swedish familial Alzheimer disease mutation
10. Mutant presenilins of Alzheimer's disease increase production of 42-residue amyloid beta-protein in both transfected cells and transgenic mice
11. Rat oligodendrocytes express muscarinic receptors coupled to phosphoinositide hydrolysis and adenylyl cyclase
12. Microglial cell activation in aging and Alzheimer disease: Partial linkage with neurofibrillary tangle burden in the hippocampus
13. Regulation of cytokine production in aging mice
14. Increased amyloid-beta42(43) in brains of mice expressing mutant presenilin 1
15. Age-associated increased interleukin-6 gene expression, late-life diseases, and frailty
16. Cleavage of amyloid beta peptide during constitutive processing of its precursor
17. Possible mechanisms of action of cobra snake venom cardiotoxins and bee venom melittin
18. Aging renders the brain vulnerable to amyloid beta-protein neurotoxicity
19. Microglia, but not astrocytes, react to sciatic nerve injury in aging rats
20. Glial-neuronal interactions in Alzheimer's disease: The potential role of a 'cytokine cycle' in disease progression
21. Amyloid beta-peptide is produced by cultured cells during normal metabolism
22. Chronic neuroinflammation in rats reproduces components of the neurobiology of Alzheimer's disease
23. Amyloid-β peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release
24. Trifluoroacetic acid pretreatment reproducibily disaggregates the amyloid-β peptide
25. Synergistic neurotoxic effects of combined treatments with cytokines in murine primary mixed neuron/glia cultures
26. Reactive oxygen species are involved in the apoptosis induced by nonsteroidal anti-inflammatory drugs in cultured gastric cells
27. Beta-amyloid neurotoxicity requires fibril formation and is inhibited by congo red
28. Alzheimer's disease and Down's syndrome
29. Neuronal origin of a cerebral amyloid: Neurofibrillary tangles of Alzheimer's disease contain the same protein as the amyloid of plaque cores and blood vessels
30. Preparation of separate astroglial and oligodendroglial cell cultures from rat cerebral tissue
31. Immune system response in Alzheimer's disease
32. Neuritic pathology and dementia in Alzheimer's disease
33. Immortalization and characterization of rat microglial cells
34. Inositol stereoisomers inhibit Aβ-induced toxicity by stabilizing a non-toxic oligomer
35. Activation of microglial cells by beta-amyloid protein and interferon-gamma
36. Correlation of astrocytic S100 beta expression with dystrophic neurites in amyloid plaques of Alzheimer's disease
37. Production of nitric oxide by glial cells: Regulation and potential roles in the CNS
38. Quantitative intracellular cytokine measure: Age-related changes in proinflammatory cytokine production
39. Nitric oxide in the central nervous system
40. Neuroprotection by the metabolic antioxidant alpha-lipoic acid
41. Neurodegeneration induced by beta-amyloid peptides in vitro: The role of peptide assembly state
42. Beta-amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease
43. The distribution of tangles, plaques and related immunohistochemical markers in healthy aging and Alzheimer's disease
44. Altered cytokine production in the elderly
45. Age-related activation of microglia and astrocytes: In vitro studies show persistent phenotypes of aging, increased proliferation, and resistance to down-regulation
46. Beta-amyloid peptide induced cytoskeletal reorganization in cultured astrocytes
47. Okadaic acid modulates the cytoskeleton changes induced by amyloid peptide (25-35) in cultured astrocytes
48. Amyloid beta-protein and the genetics of Alzheimer's disease
49. Human brain S 100 beta and S 100 beta mRNA expression increases with age: Pathogenic implications for Alzheimer's disease
50. Neuritic plaque evolution in Alzheimer's disease is accompanied by transition of activated microglia from primed to enlarged to phagocytic forms
51. Secondary structure of amyloid β peptide correlates with neurotoxic activity in vitro
52. Investigations of the lymphokine system in elderly individuals
53. Amyloidosis
54. New colorimetric cytotoxicity assay for anticancer-drug screening
55. An increased percentage of long amyloid beta protein secreted by familial amyloid beta protein precursor (beta APP717) mutants
56. Differential expression of S 100B and S 100A6(1) in the human fetal and aged cerebral cortex
57. The kinetics and magnitude of the synergistic activation of the serum amyloid A promotor by IL-1β and IL-6 is determined by the order of cytokine addition
58. Production, regulation and role of nitric oxide in glial cells
59. Fibrillar beta-amyloid induces microglial phagocytosis, expression of inducible nitric oxide synthase, and loss of a select population of neurons in the rat CNS in vivo
60. Electron micrograph of diffuse plaques. Initial stage of senile plaque formation in the Alzheimer brain
61. Increased interleukin-6 expression by microglia from brain of aged mice
62. Culture of human glial cells from brain biopsies
63. The effect of microglia on embryonic dopaminergic neuronal survival in vitro: Diffusible signals from neurons and glia change microglia from neurotoxic to neuroprotective